Clinical Trials Logo

Clinical Trial Summary

Prospective, randomized multicenter study to determine the safety and effectiveness of performing corneal collagen cross-linking (CXL) using riboflavin and UVA light in eyes with ectasia after refractive surgery.


Clinical Trial Description

Subjects are randomized to a control group or a treatment group, with the control group crossed over to the treatment group at the 3 month visit. Corneal collagen cross-linking is performed as a single treatment. Subjects are followed for 12 months after the procedure to evaluate the long term effects of corneal collagen cross-linking. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00674661
Study type Interventional
Source Glaukos Corporation
Contact
Status Completed
Phase Phase 3
Start date December 2007
Completion date November 2011

See also
  Status Clinical Trial Phase
Recruiting NCT05051917 - The Italian Coronary Artery Aneurysm and Ectasia In Patients With Acute Coronary Syndrome
Withdrawn NCT01789333 - Higher Irradiance in Keratoconus Ectasia N/A
Terminated NCT01024322 - Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Not yet recruiting NCT03858036 - Corneal Collagen Cross-Linking (CXL) Performed With "Epi-ON" Versus "Epi-OFF" in Eyes With Keratoconus and Other Corneal Ectatic Disorders Phase 3
Completed NCT02131740 - Eye Rubbing and Transient Change in Corneal Parameters N/A
Recruiting NCT01325298 - UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia Phase 2
Completed NCT00592644 - Laser Treatment Of Vascular Lesions On Vocal Cords Phase 2
Active, not recruiting NCT03080077 - Safety and Effectiveness of Corneal Crosslinking (CXL): Keratoconus and Post-Refractive Ectasia Phase 3
Recruiting NCT02118922 - A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
Enrolling by invitation NCT01081561 - Collagen Cross-Linking for Keratoconus/Ectasia With and Without Intacs Phase 2/Phase 3
Completed NCT00004327 - Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia Phase 2
Terminated NCT01189864 - Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Terminated NCT01398839 - Safety Study of the VEGA UV-A System to Treat Ectasia Phase 3
Completed NCT04649177 - Pilot Study to Investigate the Feasibility, Reliability and Efficacy of Utilizing OCT to Automate PROSE Fitting N/A
Completed NCT03896321 - Coronary Artery Ectasia in Elective Coronary Angiography : Predictors, Outcomes and Management N/A
Terminated NCT01097447 - Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)
Completed NCT02008253 - Intrastromal Corneal Ring for Ectasia After Refractive Surgery (Anel) N/A
No longer available NCT01384773 - Progressive Keratoconus or Ectasia Treatment Plan